Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

30 juil. 2013 16h00 HE | Source: Melinta Therapeutics, Inc.

Cempra, Inc. Reports Second Quarter 2013 Financial and Operating Results

CHAPEL HILL, N.C., July 30, 2013 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
23 juil. 2013 16h05 HE | Source: Melinta Therapeutics, Inc.

Cempra, Inc. to Report Second Quarter 2013 Financial and Operating Results, and Host Conference Call and Webcast on July 30, 2013

CHAPEL HILL, N.C., July 23, 2013 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP) today announced that it will report second quarter 2013 financial results and provide a business update after the close...
19 juin 2013 16h01 HE | Source: Melinta Therapeutics, Inc.

Cempra Announces Partial Exercise of Over-Allotment Option and Completion of the Public Offering of Common Stock

CHAPEL HILL, N.C., June 19, 2013 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet critical medical needs...